Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for Credit Suisse AG > News item |
Credit Suisse plans autocallable reverse convertibles tied to Alexion
By Angela McDaniels
Tacoma, Wash., Jan. 10 - Credit Suisse AG plans to price 9.5% autocallable reverse convertible securities due Jan. 23, 2015 linked to the common stock of Alexion Pharmaceuticals, Inc., according to a 424B2 filing with the Securities and Exchange Commission.
Interest will be payable monthly.
The notes will be called at par if Alexion shares close at or above the initial share price on April 18, 2014, July 18, 2014 or Oct. 20, 2014.
The payout at maturity will be par unless Alexion stock closes at or below the knock-in price, 65% of the initial share price, during the life of the notes and finishes below the initial share price, in which case the payout will be a number of Alexion shares equal to $1,000 divided by the initial share price.
Credit Suisse Securities (USA) LLC is the agent.
The notes will price Jan. 17 and settle Jan. 23.
The Cusip number is 22547QFW1.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.